204 related articles for article (PubMed ID: 11472413)
1. Inosine monophosphate dehydrogenase (IMPDH) inhibition in vitro suppresses lymphocyte proliferation and the production of immunoglobulins, autoantibodies and cytokines in splenocytes from MRLlpr/lpr mice.
Jonsson CA; Carlsten H
Clin Exp Immunol; 2001 Jun; 124(3):486-91. PubMed ID: 11472413
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolic acid inhibits inosine 5'-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells.
Jonsson CA; Carlsten H
Int Immunopharmacol; 2003 Jan; 3(1):31-7. PubMed ID: 12538032
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolic acid inhibits inosine 5'-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages.
Jonsson CA; Carlsten H
Cell Immunol; 2002; 216(1-2):93-101. PubMed ID: 12381354
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice.
Jonsson CA; Svensson L; Carlsten H
Clin Exp Immunol; 1999 Jun; 116(3):534-41. PubMed ID: 10361247
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N
J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749
[TBL] [Abstract][Full Text] [Related]
6. Effect of anti-CD134L mAb and CTLA4Ig on ConA-induced proliferation, Th cytokine secretion, and anti-dsDNA antibody production in spleen cells from lupus-prone BXSB mice.
Zhou YB; Ye RG; Li YJ; Xie CM; Wu YH
Autoimmunity; 2008 Aug; 41(5):395-404. PubMed ID: 18568645
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion.
Eugui EM; Almquist SJ; Muller CD; Allison AC
Scand J Immunol; 1991 Feb; 33(2):161-73. PubMed ID: 1826793
[TBL] [Abstract][Full Text] [Related]
8. Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5'-monophosphate dehydrogenase inhibitor.
Jain J; Almquist SJ; Heiser AD; Shlyakhter D; Leon E; Memmott C; Moody CS; Nimmesgern E; Decker C
J Pharmacol Exp Ther; 2002 Sep; 302(3):1272-7. PubMed ID: 12183689
[TBL] [Abstract][Full Text] [Related]
9. Flavonoid rutin alters the viability and function of mitogen-stimulated splenocytes and thymocytes compared with non stimulated cells.
Roseghini R; Rocha DS; Clarêncio J; Costa SL; Costa MF; Tardy M; Nascimento R; Schaer R; Velozo E; Meyer R; Freire S
Immunopharmacol Immunotoxicol; 2007; 29(2):271-85. PubMed ID: 17849271
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil ameliorates perivascular T lymphocyte inflammation and reduces the double-negative T cell population in SLE-prone MRLlpr/lpr mice.
Jonsson CA; Erlandsson M; Svensson L; Mölne J; Carlsten H
Cell Immunol; 1999 Nov; 197(2):136-44. PubMed ID: 10607431
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolic acid inhibits oleic acid-induced mesangial cell activation through both cellular reactive oxygen species and inosine monophosphate dehydrogenase 2 pathways.
Huh KH; Ahn HJ; Park J; Ju MK; Song JS; Kim MS; Kim SI; Kim YS
Pediatr Nephrol; 2009 Apr; 24(4):737-45. PubMed ID: 19093139
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of IMP dehydrogenase by mycophenolic acid in Molt F4 human malignant lymphoblasts.
Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Vogels-Mentink TM; Keizer-Garritsen JJ; Trijbels FJ
Ann Clin Biochem; 1994 Mar; 31 ( Pt 2)():174-80. PubMed ID: 7914720
[TBL] [Abstract][Full Text] [Related]
13. Inosine 5'-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells.
Dubsky PC; Friedl J; Stift A; Bachleitner-Hofmann T; Jakesz R; Gnant MF; Weigel G
Clin Chim Acta; 2006 Feb; 364(1-2):139-47. PubMed ID: 16051207
[TBL] [Abstract][Full Text] [Related]
14. Treatment with testosterone or estradiol in melatonin treated females and males MRL/MpJ-Faslpr mice induces negative effects in developing systemic lupus erythematosus.
Jimenez-Caliani AJ; Jimenez-Jorge S; Molinero P; Rubio A; Guerrero JM; Osuna C
J Pineal Res; 2008 Sep; 45(2):204-11. PubMed ID: 18507713
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr/lpr mice.
Wu WM; Suen JL; Lin BF; Chiang BL
Immunology; 2000 May; 100(1):110-8. PubMed ID: 10809966
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of multiple low dose streptozotocin-induced diabetes by mycophenolate mofetil.
Maksimovic-Ivanic D; Trajkovic V; Miljkovic DJ; Mostarica Stojkovic M; Stosic-Grujicic S
Clin Exp Immunol; 2002 Aug; 129(2):214-23. PubMed ID: 12165076
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolic Acid Inhibits p38 Mitogen-Activated Protein Kinase in Human Monocyte-Derived Dendritic Cells Stimulated by Lipopolysaccharide.
Faugaret D; Dauba A; Baron C; Velge-Roussel F; Lebranchu Y
Transplant Proc; 2009 Mar; 41(2):698-9. PubMed ID: 19328959
[TBL] [Abstract][Full Text] [Related]
18. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
19. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of mycophenolate mofetil.
Ransom JT
Ther Drug Monit; 1995 Dec; 17(6):681-4. PubMed ID: 8588241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
